(12) International Application Status Report

Received at International Bureau: 14 November 2019 (14.11.2019)

Information valid as of: 18 May 2020 (18.05.2020)

Report generated on: 24 September 2020 (24.09.2020)

(10) Publication number: (43) Publication date: (26) Publication language:
WO 2020/10891504 June 2020 (04.06.2020) English (EN)

(21) Application number: (22) Filing date: (25) Filing language:
PCT/EP2019/07996201 November 2019 (01.11.2019) English (EN)

(31) Priority number(s): (32) Priority date(s): (33) Priority status:
18209519.0 (EP)30 November 2018 (30.11.2018) Priority document received (in compliance with PCT Rule 17.1)

(51) International Patent Classification:
A23L 33/00 (2016.01); A23L 33/10 (2016.01); A61K 31/702 (2006.01)

(71) Applicant(s):
SOCIETE DES PRODUITS NESTLE S.A. [CH/CH]; Avenue Nestlé 55 1800 VEVEY (CH) (for all designated states)

(72) Inventor(s):
GARCIA-RODENAS, Clara,Lucia; Les Vergers de Lavaux A 1072 FOREL (CH)
RAMOS NIEVES, José, Manuel; Chemin de Renens 52F 1004 LAUSANNE (CH)

(74) Agent(s):
CORTICCHIATO, Olivier; Avenue Nestlé 55 1800 VEVEY (CH)

(54) Title (EN): INFANT NUTRITIONAL COMPOSITION FOR USE IN THE ENHANCEMENT OF PANCREATIC MATURATION AND INSULIN BIOSYNTHESIS
(54) Title (FR): COMPOSITION NUTRITIONNELLE POUR NOURRISSON DESTINÉE À ÊTRE UTILISÉE DANS L'AMÉLIORATION DE LA MATURATION PANCRÉATIQUE ET DE LA BIOSYNTHÈSE DE L'INSULINE

(57) Abstract:
(EN): This invention relates to nutritional compositions comprising at least one fucosylated oligosaccharide, preferably 2FL, for use in enhancing the pancreatic development and/or pancreatic maturation of infants, and/or the enhancement of the insulin biosynthesis and/or the prevention of metabolic disorder or associated diseases and/or glucose management during the nutritional intervention or later in life. The composition can be an infant formula. The composition can also comprise at least one N-acetylated oligosaccharide, preferably LnNT.
(FR): La présente invention concerne des compositions nutritionnelles comprenant au moins un oligosaccharide fucosylé, de préférence 2FL, destinées à être utilisées pour améliorer le développement pancréatique et/ou la maturation pancréatique de nourrissons, et/ou améliorer la biosynthèse de l'insuline et/ou prévenir un trouble métabolique ou des maladies associées et/ou améliorer la gestion du glucose pendant l'intervention nutritionnelle ou plus tard dans la vie. La composition peut être une préparation destinée aux nourrissons. La composition peut également comprendre au moins un oligosaccharide N-acétylé, de préférence LnNT.

International search report:
Received at International Bureau: 13 January 2020 (13.01.2020) [EP]

International Report on Patentability (IPRP) Chapter II of the PCT:
Not available

(81) Designated States:
AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
European Patent Office (EPO) : AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
African Intellectual Property Organization (OAPI) : BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG
African Regional Intellectual Property Organization (ARIPO) : BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW
Eurasian Patent Organization (EAPO) : AM, AZ, BY, KG, KZ, RU, TJ, TM

Declarations:
Declaration made as applicant's entitlement, as at the international filing date, to apply for and be granted a patent (Rules 4.17(ii) and 51bis.1(a)(ii)), in a case where the declaration under Rule 4.17(iv) is not appropriate
Declaration made as applicant's entitlement, as at the international filing date, to claim the priority of the earlier application, where the applicant is not the applicant who filed the earlier application or where the applicant's name has changed since the filing of the earlier application (Rules 4.17(iii) and 51bis.1(a)(iii))
Declaration of inventorship (Rules 4.17(iv) and 51bis.1(a)(iv)) for the purposes of the designation of the United States of America